Biogen stock quote.

What is Biogen Inc. (BIIB)'s stock price history? Over the last year, Biogen Inc.’s stock price has decreased by 25.02%. Biogen Inc. is currently approximately $227.41 per share.(Click here to get a real-time Biogen stock quote.) Biogen's drug, BIIB037, aims to slow the progression of Alzheimer's by binding to buildups known as amyloid plaques and clearing them from the ...22 brokerages have issued twelve-month price targets for Biogen's shares. Their BIIB share price targets range from $239.00 to $373.00. On average, they expect the company's stock price to reach $323.00 in the next year. This suggests a possible upside of 37.7% from the stock's current price. View analysts price targets for BIIB or view top ...My view is that it's too difficult to value Biogen right now. As a result, I don't think the stock is a buy, even after its latest Alzheimer's disease drug approval. Keith Speights has no position ...

Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock analysis for Biogen Pharmachem Industries Ltd (BIOGEN:BSE India) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Apr 25, 2023 · Biogen stock analysts project $9.56 billion in sales, which would fall 6%. They also expect the company to earn an adjusted $15.48 per share, in line with Biogen's reaffirmed outlook for profit to ...

An in-depth analysis of Biogen's intrinsic value and financial ... With a current stock price of $253.67 and a market cap of $36.70 ... Related Quotes. Symbol Last Price Change % Change; BIIB.View the latest Eli Lilly & Co. (LLY) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Shares of Biogen Inc. inched 0.24% higher to $234.64 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...Despite these favorable developments, Biogen's total revenue increased by a meager 2% year over year to $3.7 billion. Tecfidera saw a revenue increase of about 3% to $1.2 billion, accounting for ...What is Biogen Inc. (BIIB)'s stock price history? Over the last year, Biogen Inc.’s stock price has decreased by 25.02%. Biogen Inc. is currently approximately $227.41 per share. 138.99M. -77.03%. Get the latest Biogen Inc (BIIB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (78.5%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (16.7%) ; - other (4.8%): primarily revenues …

About Biogen Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s …

Nov 29, 2023 · Market Average Movement. 6.0%. 10% most volatile stocks in US Market. 15.4%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: BIIB is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week. Volatility Over Time: BIIB's weekly volatility (3%) has been stable over the past year. Nov 30, 2023 · Stock analysis for Biogen Pharmachem Industries Ltd (BIOGEN:BSE India) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Dec 1, 2023 · 22 brokerages have issued twelve-month price targets for Biogen's shares. Their BIIB share price targets range from $239.00 to $373.00. On average, they expect the company's stock price to reach $323.00 in the next year. This suggests a possible upside of 37.7% from the stock's current price. View analysts price targets for BIIB or view top ... View Biogen Inc BIIB investment & stock information. Get the latest Biogen Inc BIIB detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Biogen Inc. (BIIB.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Biogen Inc. | Nasdaq: BIIB | Nasdaq

Biogen Inc stock price (BIIB) NASDAQ: BIIB. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Biogen Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.138.99M. -77.03%. Get the latest Biogen Inc (BIIB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …BIIB stock is also up 2.1% Monday morning alongside today’s news. Investors looking for even more of the most recent stock market news will want to keep reading!Biogen's decision to price Aduhelm at $56,000 annually has led to political pressure on the company, as some view the price as too high given that the scientific data doesn't demonstrate its ...(Click here to get a real-time Biogen stock quote.) Biogen's drug, BIIB037, aims to slow the progression of Alzheimer's by binding to buildups known as amyloid plaques and clearing them from the ...Sep 26, 2023. Report of unscheduled material events or corporate event. 8-K. 0001193125-23-242617.pdf. 0001193125-23-242617.rtf. 0001193125-23-242617.xls. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML. Sep 06, 2023. Statement of changes in beneficial ownership of securities.Biogen ( BIIB -0.52%) is a business that generates more than $10 billion in revenue each year, with its multiple sclerosis treatments bringing in the bulk of its sales. But the way the stock ...

View Biogen Inc BIIB investment & stock information. Get the latest Biogen Inc BIIB detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Biogen Idec said its experimental medicine for Alzheimer's disease showed promise, prompting it to move "aggressively" into the most advanced stage of studies.Biogen Inc. (BIIBD.BCBA) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Biogen Inc. | Buenos Aires Stock Exchange: BIIBD | Buenos Aires Stock Exchange. bdb222ae9214fe1.bkYD8S55TlhXwTAw-250Ca9eP7kKz_DbkLkZcoxLBU0.JAo6vB4-DAsWj15ymQFCe9wpe4xn-ab28-17R …Nov 9, 2023 · See the latest Biogen Inc stock price (BIIB:XMEX), related news, ... Biogen stock slips after FDA approves first biosimilar to Tysabri MS treatment. MarketWatch Aug 24, 2023 10:07pm. 6 Jul 2023 ... And rounding it out with Biogen, that stock up just by a fraction here in extended trading. FDA approving its Alzheimer's drug, Leqembi ...Key Insights. Given the large stake in the stock by institutions, Biogen's stock price might be vulnerable to their trading decisions. The top 16 shareholders own 51% of the companyBiogen's decision to price Aduhelm at $56,000 annually has led to political pressure on the company, as some view the price as too high given that the scientific data doesn't demonstrate its ...Biogen shares were up less than 1% in after-hours trading on Thursday. The company has a market capitalization of $41.3 billion. “Today marks a breakthrough in the treatment of Alzheimer’s ...How much is Biogen stock worth today? ( NASDAQ: BIIB) Biogen currently has 144,898,112 outstanding shares. With Biogen stock trading at $231.95 per share, the total value of Biogen stock (market capitalization) is $33.61B. Biogen stock was originally listed at a price of $5.73 in Dec 31, 1997.Get the latest Mylan N.V. (MYL) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Biogen stock slips after FDA approves first biosimilar to Tysabri MS treatment MarketWatch. Monday, August 14, 2023. 07:17 AM ET. Biogen price target cut to $335 from $340 at Mizuho Securities MarketWatch. Monday, August 07, 2023. 07:59 AM ET. Biogen stock price target cut to $290 from $360 at Oppeneheimer MarketWatch. Saturday, August 05, 2023 ...

According to the issued ratings of 24 analysts in the last year, the consensus rating for Biogen stock is Moderate Buy based on the current 4 hold ratings and 20 buy ratings for BIIB. The average twelve-month price prediction for Biogen is $326.08 with a high price target of $373.00 and a low price target of $239.00.

Quotes delayed at least 15 minutes. Market data provided by Xignite. ... Groupon Soars, Biogen Rallies. Stocks finish the day mixed as relief package stalls, jobs report surprises.

NEE | Complete NextEra Energy Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Biogen shares fell Friday after the head of the FDA called for an investigation into the recent approval of the company's Alzheimer's drug, ... Stock Quotes, and Market Data and Analysis.6 Jul 2023 ... And rounding it out with Biogen, that stock up just by a fraction here in extended trading. FDA approving its Alzheimer's drug, Leqembi ...$ 232.65 BIIB 0.59 0.25% Nov 30, 2023 12:30 p.m. EST Real Time Quote About Biogen Inc. Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering...On today's stock market, Biogen stock rose 2.8% to close at 279.25. Eisai stock surged 4.1% and closed at 64.20. Eisai stock surged 4.1% and closed at 64.20. Biogen Stock: CMS Reimbursement KeyAbout Real-Time Quotes Nasdaq provides NLS Volume, Previous Close, Today's High & Low, and the 52 week High & Low. The intraday chart, the last-five real-time quotes and …Biogen's stock has been very volatile, reaching highs of nearly $364 and dropping as low as $223. That's a range of $141, which is half of its current share price. Much of that volatility is due ...Eisai (OTCMKTS:ESALY) pays an annual dividend of $0.88 per share and currently has a dividend yield of 1.43%. The dividend payout ratio is 101.15%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, ESALY will have a dividend payout ratio of 73.95% next year.Biogen Inc. published this content on 23 February 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 February 2021 19:09:03 UTC. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQDec 1, 2023 · See the latest Biogen Inc stock price (BIIB:XNAS), related news, valuation, dividends and more to help you make your investing decisions. BIIB: Biogen Inc - Stock Price, Quote and News - CNBC Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (78.5%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (16.7%) ; - other (4.8%): primarily revenues …

Apr 28, 2023 · BIIB stock trades at around 13x earnings and the consensus price target suggests the stock could have an 18% upside from its current price. ... And with a consensus price target of $26.78, the ... Biogen Idec (BIIB) $234.08 0.00 (0.00%) 16:00 EST BIIB Stock Quote Delayed 30 Minutes.Get the latest Biogen Inc (0R1B) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.According to 25 stock analysts, the average 12-month stock price forecast for Biogen stock is $329.2, which predicts an increase of 41.86%. The lowest target is $239 and the highest is $373. On average, analysts rate Biogen stock as a strong buy.Instagram:https://instagram. corvette 70th anniversary pricetop semiconductor etfnyse we newshumbled trader review Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing. cfgonline bank with instant debit card Biogen stock ( BIIB) is booming amid as Wall Street speculates about a potential profit boom after a promising study detailed the company's new Alzheimer's drug in partnership with Japan’s Eisai ... nyse mas Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing. Helping out BIIB stock today is the company’s latest earnings. That includes adjusted EPS of $4.02 per share alongside revenue of $2.46 billion. For comparison, Wall Street was expecting ...The stock's fall snapped a three-day winning streak. Biogen Inc. closed $86.91 below its 52-week high ($319.76), which the company achieved on June 12th. The stock …